0.01 | 0.54%
| Price and Volume | |
|---|---|
| Recent Price | 1.84 |
| 52 Week High | 3.44 |
| 52 Week Low | 1.64 |
| Avg. Daily Vol. (Mil) | 0.11 |
| Beta (3 year) | 0.83 |
| Share Related Items | |
| Mkt Cap (Mil) | 100.78 |
| Shares Out (Mil) | 54.77 |
| Float (Mil) | 37.82 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 3.20 |
| Current Ratio | 3.50 |
| LT Debt/ Equity | 0.16 |
| Total Debt / Equity | 0.19 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 1.73 |
| Price/Book | 0.81 |
| Price/Cash Flow | 82.40 |
| Per Share Data | |
| Earnings | -0.07 |
| Sales | 1.06 |
| Book Value | 2.28 |
| Cash Flow | 0.02 |
| Business Summary | |
|---|---|
| Sinovac Biotech, Ltd. is a fully integrated, profitable China-based biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases. | |
| General Information | |
| No 39, Shangdi Xi Road, Haid
Haidian District Beijing, 100085 |
|
| 1.0 | |
| www.sinovac.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 614 | |
| CEO: Weidong Yin | |
| Short Interest | |
| Current Month (Mil) | 0.67 |
| Previous Month (Mil) | 0.70 |
| Short Interest Ratio (Days) | 6.00 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -1.70 |
| Return on Investments | -2.50 |
| Profitability | |
| Gross Margin | 68.60 |
| EBIT Margin | 1.80 |
| Profit Margin | -6.30 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,423.99 | 1,314.92 | 2,839.67 | 16.25 |
Oil *
103.22
|
|
DOWN
156.70 |
DOWN
17.50 |
DOWN
31.32 |
DOWN
1.06 |
10 Yr
1.62%
SPDR Gold
152.12
|
|
-1.25%
|
-1.31%
|
-1.09%
|
-6.12%
|
Data delayed 20 minutes |
Connect with TheStreet